Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 1,342 shares at $13.35 ($18K) on 2025-06-05, disclosed to the SEC on 2025-06-06.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2026-06-17 | $16K | — | Filing → |
| DYN | SELL | 2026-05-14 | $29K | — | Filing → |
| DYN | SELL | 2026-03-06 | $13K | — | Filing → |